Couraud Sébastien, Ferretti Gilbert, Milleron Bernard, Cortot Alexis, Girard Nicolas, Gounant Valérie, Laurent François, Leleu Olivier, Quoix Elisabeth, Revel Marie-Pierre, Wislez Marie, Westeel Virginie, Zalcman Gérard, Scherpereel Arnaud, Khalil Antoine
Acute Respiratory Disease and Thoracic Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France; Intergroupe Francophone de Cancérologie Thoracique, 75009 Paris, France.
Department of Diagnostic and Interventional Radiology, CHU Grenoble Alpes, 38700 La Tronche, France.
Diagn Interv Imaging. 2021 Apr;102(4):199-211. doi: 10.1016/j.diii.2021.01.012. Epub 2021 Feb 26.
Following the American National Lung Screening Trial results in 2011 a consortium of French experts met to edit a statement. Recent results of other randomized trials gave the opportunity for our group to meet again in order to edit updated guidelines. After literature review, we provide here a new update on lung cancer screening in France. Notably, in accordance with all international guidelines, the experts renew their recommendation in favor of individual screening for lung cancer in France as per the conditions laid out in this document. In addition, the experts recommend the very rapid organization and funding of prospective studies, which, if conclusive, will enable the deployment of lung cancer screening organized at the national level.
继2011年美国国家肺癌筛查试验结果公布后,一群法国专家齐聚一堂编写了一份声明。其他随机试验的最新结果使我们这个团队有机会再次会面,以编写更新后的指南。在进行文献综述后,我们在此提供法国肺癌筛查的新进展。值得注意的是,根据所有国际指南,专家们重申他们的建议,即按照本文所述条件,在法国支持针对个体的肺癌筛查。此外,专家们建议尽快组织和资助前瞻性研究,若研究结果确凿,将有助于在全国范围内开展有组织的肺癌筛查。